Literature DB >> 25310727

Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.

Bo-Rim Yi1, Tae-Hee Kim2, Ye-Seul Kim1, Kyung-Chul Choi1.   

Abstract

Most ovarian cancers originate in the ovarian surface epithelium (OSE). Ovarian cancers might undergo epithelial-mesenchymal transition (EMT) in response to various mediators or regulators such as EMT-inducing factors. In this study, ovarian tumor specimens from patients were analyzed to demonstrate alteration of EMT-related markers according to benign and malignant types of ovarian cancers. In the three ovarian cancer cell lines, OVCAR-3, SKOV-3, and BG-1, the expression of epithelial (E-cadherin) and mesenchymal (vimentin) cell markers was identified by RNA and protein analysis. OVCAR-3 and BG-1 cells strongly expressed E-cadherin as well as morphological features such as epithelial cells, but vimentin was not observed. In contrast to these cancer cells, SKOV-3 showed a phenotype typical of mesenchymal cells. Alteration of EMT markers and EMT-related transcriptional factors were confirmed in clinical ovarian tissue samples obtained from 74 patients. E-cadherin was expressed in 57.1% of benign tumors, while vimentin was expressed in 83.3% of normal ovaries by immunohistochemistry (IHC) analysis of E-cadherin and vimentin revealed the phenomenon in the tissue specimens. Evaluation of the EMT-associated transcriptional factors Snail, Slug, and Twist revealed that Snail was overexpressed by 7.1-fold in malignant ovarian cancer compared to normal ovaries or benign tumors. Although expression levels of other factors were higher in benign and malignant ovarian tumors, they were not closely correlated with the aforementioned ovarian cancer types. Overall, Snail may affect the EMT process in ovarian cancer development and upregulation of Snail expression followed by the downregulation of E-cadherin enhances the invasiveness of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25310727     DOI: 10.3892/ijo.2014.2695

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma.

Authors:  Changmei Liu; Fangmei Yang
Journal:  Tumour Biol       Date:  2015-04-19

2.  PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance.

Authors:  Kevin Tabury; Mehri Monavarian; Eduardo Listik; Abigail K Shelton; Alex Seok Choi; Roel Quintens; Rebecca C Arend; Nadine Hempel; C Ryan Miller; Balázs Györrfy; Karthikeyan Mythreye
Journal:  Life Sci Alliance       Date:  2022-07-12

3.  Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways.

Authors:  Haofeng Lu; Lin Zhou; Hongping Zuo; Wenjin Le; Jianfei Hu; Tiequan Zhang; Mi Li; Yufeng Yuan
Journal:  Pharmacol Res Perspect       Date:  2022-06

4.  RP1-59D14.5 triggers autophagy and represses tumorigenesis and progression of prostate cancer via activation of the Hippo signaling pathway.

Authors:  Bing Zhong; Zexue Zhao; Xi Jiang
Journal:  Cell Death Dis       Date:  2022-05-13       Impact factor: 9.685

Review 5.  Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition.

Authors:  Almudena Expósito-Villén; Amelia E Aránega; Diego Franco
Journal:  Noncoding RNA       Date:  2018-05-28

6.  Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.

Authors:  Xiao-Xiang Jie; Meng Zhang; Ming Du; Qing-Qing Cai; Qing Cong; Cong-Jian Xu; Xiao-Yan Zhang
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

7.  Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.

Authors:  Mahsa Alaee; Ghazal Danesh; Manijeh Pasdar
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

8.  Down regulation of lincRNA-p21 contributes to gastric cancer development through Hippo-independent activation of YAP.

Authors:  Ying Chen; Guoqing Wei; Hongwei Xia; Huangfei Yu; Qiuling Tang; Feng Bi
Journal:  Oncotarget       Date:  2017-07-10

9.  Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer.

Authors:  Yi Zhang; Chao Li; Yi Qin; Pasquale Cepparulo; Michael Millman; Michael Chopp; Amy Kemper; Alexandra Szalad; Xuerong Lu; Lei Wang; Zheng Gang Zhang
Journal:  J Extracell Vesicles       Date:  2021-03-04

10.  A novel tumor-immune microenvironment (TIME)-on-Chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellular traps (NETs)-mediated collective tumor invasion.

Authors:  Vikram Surendran; Dylan Rutledge; Ramair Colmon; Arvind Chandrasekaran
Journal:  Biofabrication       Date:  2021-04-08       Impact factor: 9.954

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.